Avantor names Emmanuel Ligner as new CEO, begins role next week.

Avantor, a leading provider of life sciences and advanced technology products and services, has announced Emmanuel Ligner as its new CEO. Ligner brings a proven track record of value creation in the life sciences industry and will begin his role next week. The Board of Directors is committed to driving growth, expanding margins, and creating sustained shareholder value.

Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, has appointed Emmanuel Ligner as its new CEO. Ligner, a seasoned leader with a proven track record of value creation in the life sciences industry, will assume the role on August 18, 2025 [1].

The appointment comes as part of Avantor's ongoing efforts to strengthen growth and profitability in both Laboratory Solutions and Bioscience Production. Over the past 18 months, the company has seen significant strategic changes, including the successful launch of a $400 million cost transformation program, increased transparency and accountability through business resegmentation, and a focused capital allocation strategy that has reduced leverage by nearly $1.5 billion [1].

Ligner's appointment follows a series of strategic moves aimed at driving growth, expanding margins, and creating sustained shareholder value. The Board of Directors, which has been actively engaged in overseeing the company's strategy, is confident in Ligner's ability to accelerate the execution of these value creation initiatives [1].

Avantor's portfolio, which includes products used in virtually every stage of research, development, and production activities at more than 300,000 customer locations in 180 countries, positions the company for success. The company's global distribution platform and long-standing customer relationships in the life sciences industry further bolster its competitive advantage [1].

As the new CEO takes the helm, Avantor is poised to continue its trajectory of innovation and growth, with a focus on delivering value to its shareholders. The company's strategic initiatives and forward-looking statements, as outlined in its most recent filings, underscore its commitment to driving shareholder value [1].

References:
[1] https://news.avantorsciences.com/2025-08-11-Avantor-R-Reiterates-Shareholder-Value-Creation-Focus